WT-161 also induced the apoptotic cell death of various breast cancer cells by decreasing the expression levels of epidermal growth factor receptor (EGFR), epidermal growth factor receptor 2 (HER2), and estrogen receptor α (ERα), as well as downstream signaling [54]. This evidence concerns the gene ERBB2 and breast carcinoma.